According to the recent research report titled ‘Global Injectable Drugs Market (2021 Edition) - Analysis By Molecule (Small, Large), Delivery (Prefilled, Infusion, Others), Product, By Region, By Country: Market Insights and Forecast with Impact of Covid-19 (2021-2026)’, available with MarketStudyReport, global injectable drugs market was worth USD 414.88 billion in 2020 and is expected to showcase a robust CAGR over 2021-2026.
 

Rising pervasiveness of chronic diseases like cancer, diabetes, as well as auto-immune ailments such as multiple sclerosis and rheumatoid arthritis are the primary factors driving global injectable drugs industry growth.
 

Request sample copy of this report: https://www.marketstudyreport.com/request-a-sample/3855666/
 

Notably, self-administered injectable formulations such as pen injectors, auto injectors, needle-free injectors, and pre-filled syringes (PFS) are gaining popularity due to their ease of use.
 

Based on molecule type, the industry is bifurcated into small and large. Experts cite that large molecule segment is expected to expand at a strong pace over the next five years, attributable to an increase in the geriatric population and a rise in the prevalence of chronic diseases such as diabetes and cancer.
 

Elaborating on regional terrain, North America presently holds major portion of global injectable drugs market share, creditable to rapid advances in healthcare infrastructure, and strong presence of key companies in the region.
 

Besides, large investments in research and development, and growing acceptance of oncology-related pharmaceuticals in hospitals to treat various malignancies are enhancing the regional industry outlook. High demand in complicated areas such as large molecule peptides and vaccines, as well as a scarcity of injectables in the United States, contributing to the regional market growth.
 

On the other hand, Asia Pacific market is expected to observe considerable growth over 2021-2026, owing to increasing number of new medication formulations that are less water-soluble and/or have extremely low permeability to allow for effective absorption from the gastrointestinal system after oral administration.
 

Coming to competitive landscape, major companies analyzed in worldwide injectable drugs market report are Merck KGaA, Eli Lilly and Company, GlaxoSmithKline plc, Pfizer Inc., Johnson & Johnson, Novartis, AstraZeneca plc, Sanofi, Novo Nordisk, and Baxter International.